IOL Chemicals and Pharmaceuticals Limited, a prominent player in the health care sector, has been making significant strides in the pharmaceutical and chemical industries both within India and on the international stage. Incorporated in 1986 and headquartered in Ludhiana, India, the company has established itself as a key manufacturer and supplier of a diverse range of pharmaceutical and chemical products.
The company operates through two primary segments: Chemical and Pharmaceutical. The Chemical segment is renowned for its production of essential chemicals such as ethyl acetate, iso butyl benzene, acetyl chloride, mono chloro acetic acid, and acetic anhydride. These products cater to a wide array of industries, including food processing, flexible packaging, pharmaceuticals, textiles, ink, paint, pesticides, and chemical intermediates. This segment underscores IOL’s commitment to supporting various industrial processes with high-quality chemical solutions.
In the Pharmaceutical segment, IOL Chemicals and Pharmaceuticals Limited excels in the production of active pharmaceutical ingredients (APIs) that are critical for the treatment of numerous health conditions. The company’s portfolio includes APIs such as ibuprofen, metformin, fenofibrate, lamotrigine, clopidogrel bisulphate, pantoprazole sodium, ursodeoxycholic acid, losartan potassium, gabapentin, levetiracetam, and paracetamol. These ingredients are pivotal in the development of medications for anti-inflammatory, analgesic and antipyretic, anti-diabetic, anti-platelet, anti-cholesterol, anti-convulsant, anti-epileptic, anti-hypertensive, anti-cholelithic, and proton pump inhibitor treatments. The breadth and depth of IOL’s pharmaceutical offerings highlight its role as a vital contributor to global health care.
Financially, IOL Chemicals and Pharmaceuticals Limited has demonstrated robust performance. As of May 26, 2026, the company’s close price stood at 131.4 INR, with a 52-week high of 138.9 INR and a low of 67.19 INR. The market capitalization of the company is a substantial 419,626,967,004 INR, reflecting its significant presence in the market. The price-to-earnings ratio of 28.02417 indicates investor confidence in the company’s growth potential and profitability.
Listed on the National Stock Exchange of India, IOL Chemicals and Pharmaceuticals Limited continues to expand its reach and influence in the global market. The company’s strategic focus on innovation and quality ensures that it remains at the forefront of the pharmaceutical and chemical industries. As it moves forward, IOL is well-positioned to capitalize on emerging opportunities and address the evolving needs of its diverse customer base.
In summary, IOL Chemicals and Pharmaceuticals Limited stands as a testament to sustained growth and excellence in the health care sector. With its comprehensive product offerings and strong financial foundation, the company is poised for continued success in the years to come.
